Hiscox Ltd Stock London S.E.
Equities
BMG4593F1207
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBX | - |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.95B | Sales 2025 * | 4.27B 5.43B | Capitalization | 3.86B 4.91B |
---|---|---|---|---|---|
Net income 2024 * | 466M 593M | Net income 2025 * | 500M 636M | EV / Sales 2024 * | 1.12 x |
Net Debt 2024 * | 513M 652M | Net Debt 2025 * | 513M 652M | EV / Sales 2025 * | 1.02 x |
P/E ratio 2024 * |
8.28
x | P/E ratio 2025 * |
7.6
x | Employees | - |
Yield 2024 * |
2.85% | Yield 2025 * |
3.16% | Free-Float | 97.41% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
1st Jan change | Capi. | |
---|---|---|
+59.88% | 69.8B | |
+12.21% | 50.45B | |
+11.82% | 48.78B | |
+17.02% | 43.23B | |
+35.42% | 37.61B | |
+71.96% | 32.07B | |
+12.85% | 29.81B | |
+26.83% | 25.49B | |
+0.45% | 21.5B |